Show metadata Hide metadata

(19)

(11)

2 792 364

(13)

(51)

IPC

C07K14/47(2006-01-01)

A61K38/17(2006-01-01)

A61P35/00(2006-01-01)

(21) (22)

Application

2022106434, 2022-03-11

(24)

Start date

2022-03-11

(22)

Actual filing date

2022-03-11

(45)

Published

2023-03-21

(72)

Inventor

Lyukmanova Ekaterina NazymovnaShenkarev Zakhar OlegovichShulepko Mikhail AnatolevichBychkov Maksim LeonidovichKulbatskii Dmitrii SergeevichKirpichnikov Mikhail Petrovich

(73)

Holder

Federalnoe Gosudarstvennoe Biudzhetnoe Uchrezhdenie Nauki Institut Bioorganicheskoi Khimii Im. Akademikov M.M. Shemiakina I Iu.A. Ovchinnikova Rossiiskoi Akademii Nauk Ran)

PEPTIDE HAVING ACTIVITY OF HUMAN SLURP-1 PROTEIN AND ITS APPLICATION FOR SUPPRESSION OF GROWTH OF CARCINOMA AND GLIOMA, PHARMACEUTICAL COMPOSITION FOR SUPPRESSION OF GROWTH OF CARCINOMA AND GLIOMA, AND METHOD FOR SUPPRESSION OF GROWTH OF CARCINOMA AND GLIOMA USING THE SPECIFIED PEPTIDE Russian patent published in 2023 - IPC C07K14/47 A61K38/17 A61P35/00

Abstract RU 2792364 C1

FIELD: biotechnology; medicine.

SUBSTANCE: invention relates to a peptide having the activity of a human SLURP-1 protein and its use for suppressing the growth of carcinomas and gliomas, to a pharmaceutical composition for suppressing the growth of carcinomas and gliomas containing the specified peptide, and to a method for suppressing the growth of carcinomas and gliomas in a subject suffering from these diseases.

EFFECT: obtaining a peptide with the activity of a human SLURP-1 protein to suppress the growth of carcinomas and gliomas.

8 cl, 6 dwg, 5 ex

Similar patents RU2792364C1

Title	Year	Author	Number
PEPTIDE HAVING LYNX1 PROTEIN ACTIVITY (EMBODIMENTS), PHARMACEUTICAL COMPOSITION FOR TREATING ANXIETY DISORDERS AND DEPRESSION OR CORRECTION OF COGNITIVE DISORDERS IN NEURODEGENERATIVE DISEASES, CONTAINING SAID PEPTIDE, AND METHOD OF TREATING AND CORRECTING SAID DISORDERS	2020	Kirpichnikov Mikhail Petrovich Lyukmanova Ekaterina Nazymovna Shenkarev Zakhar Olegovich Shulepko Mikhail Anatolevich	RU2734649C1
PEPTIDES AND PEPTIDOMIMETICS IN COMBINATION WITH CONTROL POINT INHIBITING AGENTS FOR TREATING CANCER	2016	Kawabe, Takumi	RU2739201C2
PEPTIDES AND PEPTIDOMIMETICS FOR COMBINED USE AND TREATMENT IN A SUBPOPULATION OF PATIENTS WITH CANCER DISEASES	2014	Kavabe Takumi Mine Naoki Saito Naoya Sakakibara Kejiti Sato Takudzi	RU2732440C2
IMPROVED PEPTIDE DRUGS FOR TREATMENT OF NASH AND OTHER DISORDERS	2019	Nestor, John J.	RU2790209C2
STRUCTURES HAVING SIRP-ALPHA DOMAIN OR ITS VERSION	2016	Ponz Khaume Deming Laura Gudman Kori Sim Bang Dzhanet Kauder Stiven Elliot Van Khun Ko Trejsi Chia-Chien	RU2740672C2
NOVEL CONJUGATES OF MONTELUKAST AND PEPTIDES	2019	Samuelsson, Bengt Ingemar Gu, Ming	RU2838061C2
ANTI-TIGIT ANTIBODIES AND METHODS OF USING	2016	Grogan, Jane, L. Johnston, Robert, J. Wu, Yan Liang, Wei-Ching Lupardus, Patrick Yadav, Mahesh Seshasayee, Dhaya Hazen, Meredith	RU2732591C2
USE OF RECOMBINANT ANALOGUE OF WATER-SOLUBLE DOMAIN OF LYNX1 PROTEIN FOR CELL GROWTH INHIBITION BY CARCINOMA	2019	Kirpichnikov Mikhail Petrovich Lyukmanova Ekaterina Nazymovna Shenkarev Zakhar Olegovich Bychkov Maksim Leonidovich	RU2721129C1
PEPTIDES AND THEIR USE IN TREATMENT OF DISEASES, DISORDERS OR CONDITIONS ASSOCIATED WITH MUTANT p53	2017	Rotter, Varda Oren, Moshe Tal, Perry Eizenberger, Shay Ben-Shimon, Avi	RU2762089C2
APPLICATION OF RECOMBINANT ANALOGUE OF HUMAN PROTEIN SLURP-1 IN COMBINATION WITH CYTOSTATICS OR PROTEASOME INHIBITOR PRODUCTS FOR INHIBITING GROWTH OF CARCINOMAS	2020	Liukmanova Ekaterina Nazymovna Shenkarev Zakhar Olegovich Shulepko Mikhail Anatolevich Bychkov Maksim Leonidovich Kirpichnikov Mikhail Petrovich	RU2751132C1

RU 2 792 364 C1

Authors

Lyukmanova Ekaterina Nazymovna

Shenkarev Zakhar Olegovich

Shulepko Mikhail Anatolevich

Bychkov Maksim Leonidovich

Kulbatskii Dmitrii Sergeevich

Kirpichnikov Mikhail Petrovich

Dates

2023-03-21—Published

2022-03-11—Filed